340B Reporting and Accountability Act
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
0pct
0d open
vs 5,649 other S bills in the 118th — cohort avg 33d
No CRS summary is available for this bill yet. The source title, actions, sponsors, and text versions below come from Congress.gov.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (4)
2024 · third_quarter · Pharmacy
The 340B Drug Pricing Program; H.R. 2534, The Protect 340B Act; FY24 and FY25 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations bills. HR 3290,to amend title III of the Public Health Service Act to ensure transparency and oversight of the 340B drug discount program. H.R.3561 - PATIENT Act of 2023, The Stop Drug Shortages Act (Draft legislation- House), H.R. 5378: Lower Costs, More Transparency Act, S. 1182: 340B Reporting and Accountability Act; S.1133: 340B Accountability Act of 2023,S.1038: Drug Price Transparency in Medicaid Act of 2023,H.R.1613: Drug Price Transparency in Medicaid Act of 2023,H.R.198: Drug Pricing Transparency and Accountability Act; S. 2973: Modernizing and Ensuring PBM Accountability Act, Draft Senate legislation the SUSTAIN 340B Act, HR 7635 and S. 5021, the 340B PATIENTS Act.H.R. 8574, 340B ACCESS Act: H.R.8144 - Rural 340B Access Act of 2024
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Introduced in Senate
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Client expense: $345,454 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), Office of Management & Budget (OMB), SENATE
2024 · fourth_quarter · Pharmacy
The 340B Drug Pricing Program; H.R. 2534, The Protect 340B Act; FY24 and FY25 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations bills. HR 3290,to amend title III of the Public Health Service Act to ensure transparency and oversight of the 340B drug discount program. H.R.3561 - PATIENT Act of 2023, The Stop Drug Shortages Act (Draft legislation- House), H.R. 5378: Lower Costs, More Transparency Act, S. 1182: 340B Reporting and Accountability Act; S.1133: 340B Accountability Act of 2023,S.1038: Drug Price Transparency in Medicaid Act of 2023,H.R.1613: Drug Price Transparency in Medicaid Act of 2023,H.R.198: Drug Pricing Transparency and Accountability Act; S. 2973: Modernizing and Ensuring PBM Accountability Act, Draft Senate legislation the SUSTAIN 340B Act, HR 7635 and S. 5021, the 340B PATIENTS Act.H.R. 8574, 340B ACCESS Act: H.R.8144 - Rural 340B Access Act of 2024
Client expense: $260,046 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), Office of Management & Budget (OMB), SENATE
2024 · fourth_quarter · Pharmacy
The 340B Drug Pricing Program; H.R. 2534, The Protect 340B Act; FY24 and FY25 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations bills. HR 3290,to amend title III of the Public Health Service Act to ensure transparency and oversight of the 340B drug discount program. H.R.3561 - PATIENT Act of 2023, The Stop Drug Shortages Act (Draft legislation- House), H.R. 5378: Lower Costs, More Transparency Act, S. 1182: 340B Reporting and Accountability Act; S.1133: 340B Accountability Act of 2023,S.1038: Drug Price Transparency in Medicaid Act of 2023,H.R.1613: Drug Price Transparency in Medicaid Act of 2023,H.R.198: Drug Pricing Transparency and Accountability Act; S. 2973: Modernizing and Ensuring PBM Accountability Act, Draft Senate legislation the SUSTAIN 340B Act, HR 7635 and S. 5021, the 340B PATIENTS Act.H.R. 8574, 340B ACCESS Act: H.R.8144 - Rural 340B Access Act of 2024
Client expense: $260,046 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), Office of Management & Budget (OMB), SENATE
2024 · third_quarter · Pharmacy
The 340B Drug Pricing Program; H.R. 2534, The Protect 340B Act; FY24 and FY25 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations bills. HR 3290,to amend title III of the Public Health Service Act to ensure transparency and oversight of the 340B drug discount program. H.R.3561 - PATIENT Act of 2023, The Stop Drug Shortages Act (Draft legislation- House), H.R. 5378: Lower Costs, More Transparency Act, S. 1182: 340B Reporting and Accountability Act; S.1133: 340B Accountability Act of 2023,S.1038: Drug Price Transparency in Medicaid Act of 2023,H.R.1613: Drug Price Transparency in Medicaid Act of 2023,H.R.198: Drug Pricing Transparency and Accountability Act; S. 2973: Modernizing and Ensuring PBM Accountability Act, Draft Senate legislation the SUSTAIN 340B Act, HR 7635 and S. 5021, the 340B PATIENTS Act.H.R. 8574, 340B ACCESS Act: H.R.8144 - Rural 340B Access Act of 2024
Client expense: $345,454 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), Office of Management & Budget (OMB), SENATE
2024 · second_quarter · Pharmacy
The 340B Drug Pricing Program; H.R. 2534, The Protect 340B Act; FY24 and FY25 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations bills. HR 3290,to amend title III of the Public Health Service Act to ensure transparency and oversight of the 340B drug discount program. H.R.3561 - PATIENT Act of 2023, The Stop Drug Shortages Act (Draft legislation- House), H.R. 5378: Lower Costs, More Transparency Act, S. 1182: 340B Reporting and Accountability Act; S.1133: 340B Accountability Act of 2023,S.1038: Drug Price Transparency in Medicaid Act of 2023,H.R.1613: Drug Price Transparency in Medicaid Act of 2023,H.R.198: Drug Pricing Transparency and Accountability Act; S. 2973: Modernizing and Ensuring PBM Accountability Act, Draft Senate legislation the SUSTAIN 340B Act, HR 7635, the 340B PATIENTS Act.H.R. 8574, 340B ACCESS Act
Client expense: $315,115 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), Office of Management & Budget (OMB), SENATE
2024 · first_quarter · Pharmacy
The 340B Drug Pricing Program; H.R. 2534, The Protect 340B Act; FY24 and FY25 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations bills. HR 3290,to amend title III of the Public Health Service Act to ensure transparency and oversight of the 340B drug discount program. H.R.3561 - PATIENT Act of 2023, The Stop Drug Shortages Act (Draft legislation- House), H.R. 5378: Lower Costs, More Transparency Act, S. 1182: 340B Reporting and Accountability Act; S.1133: 340B Accountability Act of 2023,S.1038: Drug Price Transparency in Medicaid Act of 2023,H.R.1613: Drug Price Transparency in Medicaid Act of 2023,H.R.198: Drug Pricing Transparency and Accountability Act; S. 2973: Modernizing and Ensuring PBM Accountability Act, Draft Senate legislation the SUSTAIN 340B Act, HR 7635, the 340B PATIENTS Act.
Client expense: $391,233 · Firm income: Not reported
2023 · fourth_quarter · Medicare/Medicaid
Higher education healthcare related issues, generally Monitor the following: Hospital at Home Program, Entirety Graduate Medical Education (GME) Medicare Wage Index Disproportionate Share Hospital (DSH) Payments Alabama Area Health Education Centers (AHEC) Medicare Reimbursement related issues H.R.3290, To amend title III of the Public Health Service Act to ensure transparency and oversight of the 340B drug discount program, Entirety S.1133, 340B Accountability Act of 2023, Entirety S.1182, 340B Reporting and Accountability Act, Entirety H.R.2534, PROTECT 340B Act of 2023, Entirety Medicaid Provider Hold Harmless Arrangements Low Volume Hospitals and Medicare Dependent Hospitals CMS Hospital Payment, Provider relief issues
Client expense: Not reported · Firm income: $40,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2023 · fourth_quarter · Medicare/Medicaid
Monitor the following: Telehealth reimbursement issues Hospital Acquisition and Billing The Hospital Inpatient Payment Systems for Acute Care Hospitals and Long Term care Hospital Prospective Payment System (IPPS), Proposed Rule changes Disproportionate share hospital payments Graduate Medical Education (GME) issues Medicaid and Medicare Reform H.R.3290, To amend title III of the Public Health Service Act to ensure transparency and oversight of the 340B drug discount program, Entirety S.1133, 340B Accountability Act of 2023, Entirety S.1182, 340B Reporting and Accountability Act, Entirety H.R.2534, PROTECT 340B Act of 2023, Entirety
Client expense: Not reported · Firm income: $40,000
2023 · fourth_quarter · Pharmacy
The 340B Drug Pricing Program; The Protect 340B Act; FY24 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations bill. HR 3290,to amend title III of the Public Health Service Act to ensure transparency and oversight of the 340B drug discount program. H.R.3561 - PATIENT Act of 2023, The Stop Drug Shortages Act (Draft legislation- House), H.R. 5378: Lower Costs, More Transparency Act, S. 1182: 340B Reporting and Accountability Act; S.1133: 340B Accountability Act of 2023,S.1038: Drug Price Transparency in Medicaid Act of 2023,H.R.1613: Drug Price Transparency in Medicaid Act of 2023,H.R.198: Drug Pricing Transparency and Accountability Act; S. 2973: Modernizing and Ensuring PBM Accountability Act
Client expense: $249,606 · Firm income: Not reported
2023 · fourth_quarter · Health Issues
Health Care Workforce Programs and Policies. H.R. 3281, the Transparent PRICE Act. All Provisions. H.R. 2666, the Medicaid VBPs for Patients (MVP) Act. All Provisions. H.R. 3284, the Providers and Payers COMPETE Act. All Provisions. H.R. 3290, To amend title III of the Public Health Service Act. All Provisions. H.R. 3237 - Requiring a Separate Identification Number and an Attestation for Each Off-Campus Outpatient Department of a Provider. All Provisions. H.R. 3262 - Mandatory Reporting with Respect to Certain Health-Related Ownership Information. All Provisions. H.R. 3248 - The Diagnostic Lab Testing Transparency Act. All Provisions H.R. 3282 - The Promoting Transparency and Healthy Competition in Medicare Act. All Provisions H.R. 2679 - The PBM Accountability Act. All Provisions. H.R. 2559 - The Strengthening Community Care Act of 2023. All Provisions. H.R. 2550 - The Special Diabetes Program Reauthorization Act of 2023. All Provisions H.R. 2547 - The Special Diabetes Program for Indians Reauthorization Act of 2023. All Provisions. H.R. 2665 - The Supporting Safety Net Hospitals Act. All Provisions. H.R. 1613 - The Drug Price Transparency in Medicaid Act of 2023. All Provisions. S. 1002, No Unreasonable Payments, Coding, or Diagnoses for Elderly (No UPCODE Act). All Provisions. S. 1182 - 340B - To amend the Public Health Service Act to increase the transparency and accountability of the drug discount program, and for other purposes. All Provisions. S.1403 Medical Student Authorization Act of 2023. All Provisions. S.2840 Bipartisan Primary Care and Health Workforce Act. All Provisions. H.R. 5378 Lower Cost, More Transparency Act. All Provisions. Potential Grants and Procurement Programs Related to U.S. based manufacturing of Personal Protective Equipment (PPE).
Client expense: $200,000 · Firm income: Not reported
2023 · fourth_quarter · Medicare/Medicaid
CMS'CY 2024 Advance Notice of Methodological Changes for Medicare Capitation Rates for Part C and Part D Payment Policies. Issues surrounding changes to risk adjustment mechanisms. Nomination of Chief Executive Officer for appointment to the Medicaid and CHIP Payment and Access Commission H.R. 3281, the Transparent PRICE Act. All Provisions. H.R. 2666, the Medicaid VBPs for Patients (MVP) Act. All Provisions. H.R. 3284, the Providers and Payers COMPETE Act. All Provisions. H.R. 3290, To amend title III of the Public Health Service Act. All Provisions. H.R. 3237 - Requiring a Separate Identification Number and an Attestation for Each Off-Campus Outpatient Department of a Provider. All Provisions. H.R. 3262 - Mandatory Reporting with Respect to Certain Health-Related Ownership Information. All Provisions. H.R. 3248 - The Diagnostic Lab Testing Transparency Act. All Provisions H.R. 3282 - The Promoting Transparency and Healthy Competition in Medicare Act. All Provisions H.R. 2679 - The PBM Accountability Act. All Provisions. H.R. 2559 - The Strengthening Community Care Act of 2023. All Provisions. H.R. 2550 - The Special Diabetes Program Reauthorization Act of 2023. All Provisions H.R. 2547 - The Special Diabetes Program for Indians Reauthorization Act of 2023. All Provisions. H.R. 2665 - The Supporting Safety Net Hospitals Act. All Provisions. H.R. 1613 - The Drug Price Transparency in Medicaid Act of 2023. All Provisions. S. 1002, No Unreasonable Payments, Coding, or Diagnoses for Elderly (No UPCODE Act). All Provisions. S. 1182 - 340B - To amend the Public Health Service Act to increase the transparency and accountability of the drug discount program, and for other purposes. All Provisions. H.R. 5378 Lower Cost, More Transparency Act. All Provisions. H.R. 5013 Value in Health Care Act of 2023. All Provisions. Medicaid Supplemental Payment Technical Assistance
340B Drug Discount Program H.R. 3290, To amend title III of the Public Health Service Act to ensure transparency and oversight of the 340B drug discount program. H.R. 2534, PROTECT 340B Act of 2023 340B Contract Pharmacy Policy S. 1133, 340B Accountability Act Accelerated Approval Advanced Research Projects Agency for Health (ARPA-H) Alternative Funding Programs Biosimilar approval and reimbursement policy issues Buy American Executive Order Cancer Moonshot Cell, gene and radioligand therapies Co-pay accumulator programs Diversity in Clinical Trials Drug cost and pricing policy issues Drug Importation and counterfeiting policy issues Drug shortages policy issues FDA modernization policy issues Foreign manufacturing policy issues Genetically Targeted Technologies H.R. 2534, Preserving Rules Ordered for the Entities Covered Through (PROTECT) 340B Act H.R. 2679, Pharmacy Benefits Manager Accountability Act H.R. 5376, Inflation Reduction Act H.R. 4822, Health Care Price Transparency Act of 2023 Inflation Reduction Act Implementation H.R. 5416, The Give Kids a Chance Act The Medicaid VBPs for Patients (MVP) Act H.R. 830/S. 1375, HELP Co-pays Act H.R. 1613, The Drug Price Transparency in Medicaid Act H.R. 198, Drug Pricing Transparency and Accountability Act H.R. 3561, Promoting Access to Treatments and Increasing Extremely Needed Transparency Medicaid Payment Reform Notice of Benefit Payment Parameters (NBPP) Orphan drug policy issues Outcomes based contracting/value based arrangements Patient assistance program policy issues PDUFA, BSUFA, GDUFA Pharmaceutical quality Pharmaceutical supply chain Pharmacy benefit manager policy issues Priority Review Voucher (PRV) Reauthorization of PAHPA Regulatory efficiencies policy issues S. 652/H.R. 2630, Safe Step Act S. 79/H.R. 1717, Interagency Patent Coordination and Improvement Act of 2023 S. 2837, 340B Accountability Act 2021 S. 476/HR. 5567 The Maintaining Investments in New Innovations (MINI) Act H.R. 5539, ORPHAN Cures Act S. 1246, SMART Prices Act S. 127, The Pharmacy Benefit Manager Transparency Act of 2023 S. 1339, Pharmacy Benefit Manager Reform Act S. 1542, Delinking Reveue from Unfair Gouging (DRUG) Act S. 1967, Patients Before Middlemen Act S. 2973 Modernizing and Ensuring PBM Accountability (MEPA) Act H.R. 5378, Lower Costs, More Transparency Act H.R. 2880, Protecting Patients Against PBM Abuses Act Step Therapy Transparency policy issues Utilization management issues Health industry vertical integration CBO modeling 340B Program Implementation & Oversight 340B Accountability Act S. 1182: The 340B Reporting and Accountability Act H.R.2534: PROTECT 340B Act of 2023 H.R.2408: Access to Innovative Treatments Act of 2023 H.R.1790: Biologics Competition Act of 2023 S.113: Prescription Pricing for the People Act of 2023 S.150: Affordable Prescriptions for Patients Act of 2023 Drug Benefit Design
2023 · third_quarter · Medicare/Medicaid
CMS'CY 2024 Advance Notice of Methodological Changes for Medicare Capitation Rates for Part C and Part D Payment Policies. Issues surrounding changes to risk adjustment mechanisms. Nomination of Chief Executive Officer for appointment to the Medicaid and CHIP Payment and Access Commission H.R. 3281, the Transparent PRICE Act. All Provisions. H.R. 2666, the Medicaid VBPs for Patients (MVP) Act. All Provisions. H.R. 3284, the Providers and Payers COMPETE Act. All Provisions. H.R. 3290, To amend title III of the Public Health Service Act. All Provisions. H.R. 3237 - Requiring a Separate Identification Number and an Attestation for Each Off-Campus Outpatient Department of a Provider. All Provisions. H.R. 3262 - Mandatory Reporting with Respect to Certain Health-Related Ownership Information. All Provisions. H.R. 3248 - The Diagnostic Lab Testing Transparency Act. All Provisions H.R. 3282 - The Promoting Transparency and Healthy Competition in Medicare Act. All Provisions H.R. 2679 - The PBM Accountability Act. All Provisions. H.R. 2559 - The Strengthening Community Care Act of 2023. All Provisions. H.R. 2550 - The Special Diabetes Program Reauthorization Act of 2023. All Provisions H.R. 2547 - The Special Diabetes Program for Indians Reauthorization Act of 2023. All Provisions. H.R. 2665 - The Supporting Safety Net Hospitals Act. All Provisions. H.R. 1613 - The Drug Price Transparency in Medicaid Act of 2023. All Provisions. S. 1002, No Unreasonable Payments, Coding, or Diagnoses for Elderly (No UPCODE Act). All Provisions. S. 1182 - 340B - To amend the Public Health Service Act to increase the transparency and accountability of the drug discount program, and for other purposes. All Provisions. H.R. 5378 Lower Cost, More Transparency Act. All Provisions. H.R. 5013 Value in Health Care Act of 2023. All Provisions.
2023 · third_quarter · Health Issues
Health Care Workforce Programs and Policies. H.R. 3281, the Transparent PRICE Act. All Provisions. H.R. 2666, the Medicaid VBPs for Patients (MVP) Act. All Provisions. H.R. 3284, the Providers and Payers COMPETE Act. All Provisions. H.R. 3290, To amend title III of the Public Health Service Act. All Provisions. H.R. 3237 - Requiring a Separate Identification Number and an Attestation for Each Off-Campus Outpatient Department of a Provider. All Provisions. H.R. 3262 - Mandatory Reporting with Respect to Certain Health-Related Ownership Information. All Provisions. H.R. 3248 - The Diagnostic Lab Testing Transparency Act. All Provisions H.R. 3282 - The Promoting Transparency and Healthy Competition in Medicare Act. All Provisions H.R. 2679 - The PBM Accountability Act. All Provisions. H.R. 2559 - The Strengthening Community Care Act of 2023. All Provisions. H.R. 2550 - The Special Diabetes Program Reauthorization Act of 2023. All Provisions H.R. 2547 - The Special Diabetes Program for Indians Reauthorization Act of 2023. All Provisions. H.R. 2665 - The Supporting Safety Net Hospitals Act. All Provisions. H.R. 1613 - The Drug Price Transparency in Medicaid Act of 2023. All Provisions. S. 1002, No Unreasonable Payments, Coding, or Diagnoses for Elderly (No UPCODE Act). All Provisions. S. 1182 - 340B - To amend the Public Health Service Act to increase the transparency and accountability of the drug discount program, and for other purposes. All Provisions. S.1403 Medical Student Authorization Act of 2023. All Provisions. S.2840 Bipartisan Primary Care and Health Workforce Act. All Provisions. H.R. 5378 Lower Cost, More Transparency Act. All Provisions.
Client expense: $175,000 · Firm income: Not reported
2023 · third_quarter · Medicare/Medicaid
Monitor the following: Hospital at Home Program, Entirety Graduate Medical Education (GME) Medicare Wage Index Disproportionate Share Hospital (DSH) Payments Alabama Area Health Education Centers (AHEC) Medicare Reimbursement related issues H.R.3290, To amend title III of the Public Health Service Act to ensure transparency and oversight of the 340B drug discount program, Entirety S.1133, 340B Accountability Act of 2023, Entirety S.1182, 340B Reporting and Accountability Act, Entirety H.R.2534, PROTECT 340B Act of 2023, Entirety Medicaid Provider Hold Harmless Arrangements Low Volume Hospitals and Medicare Dependent Hospitals CMS Hospital Payment, Provider relief issues
Client expense: Not reported · Firm income: $30,000
2023 · third_quarter · Pharmacy
The 340B Drug Pricing Program; The Protect 340B Act; FY24 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations bill. HR 3290,to amend title III of the Public Health Service Act to ensure transparency and oversight of the 340B drug discount program. H.R.3561 - PATIENT Act of 2023, The Stop Drug Shortages Act (Draft legislation- House), H.R. 5378: Lower Costs, More Transparency Act, S. 1182: 340B Reporting and Accountability Act; S.1133: 340B Accountability Act of 2023,S.1038: Drug Price Transparency in Medicaid Act of 2023,H.R.1613: Drug Price Transparency in Medicaid Act of 2023,H.R.198: Drug Pricing Transparency and Accountability Act; S. 2973: Modernizing and Ensuring PBM Accountability Act
Client expense: $313,537 · Firm income: Not reported
2023 · third_quarter · Medicare/Medicaid
Monitor the following: Telehealth reimbursement issues Hospital Acquisition and Billing The Hospital Inpatient Payment Systems for Acute Care Hospitals and Long Term care Hospital Prospective Payment System (IPPS), Proposed Rule changes Disproportionate share hospital payments Graduate Medical Education (GME) issues Medicaid and Medicare Reform H.R.3290, To amend title III of the Public Health Service Act to ensure transparency and oversight of the 340B drug discount program, Entirety S.1133, 340B Accountability Act of 2023, Entirety S.1182, 340B Reporting and Accountability Act, Entirety H.R.2534, PROTECT 340B Act of 2023, Entirety
Client expense: Not reported · Firm income: $30,000
2023 · second_quarter · Medicare/Medicaid
Monitor the following: Telehealth reimbursement issues Hospital Acquisition and Billing The Hospital Inpatient Payment Systems for Acute Care Hospitals and Long Term care Hospital Prospective Payment System (IPPS), Proposed Rule changes Disproportionate share hospital payments Graduate Medical Education (GME) issues Medicaid and Medicare Reform H.R.3290, To amend title III of the Public Health Service Act to ensure transparency and oversight of the 340B drug discount program, Entirety S.1133, 340B Accountability Act of 2023, Entirety S.1182, 340B Reporting and Accountability Act, Entirety H.R.2534, PROTECT 340B Act of 2023, Entirety
Client expense: Not reported · Firm income: $40,000
2023 · second_quarter · Medicare/Medicaid
Monitor the following: Hospital at Home Program, Entirety Graduate Medical Education (GME) Medicare Wage Index Disproportionate Share Hospital (DSH) Payments Alabama Area Health Education Centers (AHEC) Agency for Healthcare Research and Quality related issues IDeA program related issues Medicare Reimbursement related issues H.R.3290, To amend title III of the Public Health Service Act to ensure transparency and oversight of the 340B drug discount program, Entirety S.1133, 340B Accountability Act of 2023, Entirety S.1182, 340B Reporting and Accountability Act, Entirety H.R.2534, PROTECT 340B Act of 2023, Entirety Medicaid Provider Hold Harmless Arrangements Low Volume Hospitals and Medicare Dependent Hospitals CMS Hospital Payment, Provider relief issues
Client expense: Not reported · Firm income: $80,000
2023 · second_quarter · Medicare/Medicaid
Monitor the following: Hospital at Home Program, Entirety Graduate Medical Education (GME) Medicare Wage Index Disproportionate Share Hospital (DSH) Payments Alabama Area Health Education Centers (AHEC) Agency for Healthcare Research and Quality related issues IDeA program related issues Medicare Reimbursement related issues H.R.3290, To amend title III of the Public Health Service Act to ensure transparency and oversight of the 340B drug discount program, Entirety S.1133, 340B Accountability Act of 2023, Entirety S.1182, 340B Reporting and Accountability Act, Entirety H.R.2534, PROTECT 340B Act of 2023, Entirety Medicaid Provider Hold Harmless Arrangements Low Volume Hospitals and Medicare Dependent Hospitals CMS Hospital Payment, Provider relief issues
Client expense: Not reported · Firm income: $40,000
2023 · second_quarter · Medicare/Medicaid
CMS'CY 2024 Advance Notice of Methodological Changes for Medicare Capitation Rates for Part C and Part D Payment Policies. Issues surrounding changes to risk adjustment mechanisms. Nomination of Chief Executive Officer for appointment to the Medicaid and CHIP Payment and Access Commission H.R. 3281, the Transparent PRICE Act. All Provisions. H.R. 2666, the Medicaid VBPs for Patients (MVP) Act. All Provisions. H.R. 3284, the Providers and Payers COMPETE Act. All Provisions. H.R. 3290, To amend title III of the Public Health Service Act. All Provisions. H.R. 3237 - Requiring a Separate Identification Number and an Attestation for Each Off-Campus Outpatient Department of a Provider. All Provisions. H.R. 3262 - Mandatory Reporting with Respect to Certain Health-Related Ownership Information. All Provisions. H.R. 3248 - The Diagnostic Lab Testing Transparency Act. All Provisions H.R. 3282 - The Promoting Transparency and Healthy Competition in Medicare Act. All Provisions H.R. 2679 - The PBM Accountability Act. All Provisions. H.R. 2559 - The Strengthening Community Care Act of 2023. All Provisions. H.R. 2550 - The Special Diabetes Program Reauthorization Act of 2023. All Provisions H.R. 2547 - The Special Diabetes Program for Indians Reauthorization Act of 2023. All Provisions. H.R. 2665 - The Supporting Safety Net Hospitals Act. All Provisions. H.R. 1613 - The Drug Price Transparency in Medicaid Act of 2023. All Provisions. S. 1002, No Unreasonable Payments, Coding, or Diagnoses for Elderly (No UPCODE Act). All Provisions. S. 1182 - 340B - To amend the Public Health Service Act to increase the transparency and accountability of the drug discount program, and for other purposes. All Provisions.
Client expense: $175,000 · Firm income: Not reported
2023 · second_quarter · Health Issues
Health Care Workforce Programs and Policies. H.R. 3281, the Transparent PRICE Act. All Provisions. H.R. 2666, the Medicaid VBPs for Patients (MVP) Act. All Provisions. H.R. 3284, the Providers and Payers COMPETE Act. All Provisions. H.R. 3290, To amend title III of the Public Health Service Act. All Provisions. H.R. 3237 - Requiring a Separate Identification Number and an Attestation for Each Off-Campus Outpatient Department of a Provider. All Provisions. H.R. 3262 - Mandatory Reporting with Respect to Certain Health-Related Ownership Information. All Provisions. H.R. 3248 - The Diagnostic Lab Testing Transparency Act. All Provisions H.R. 3282 - The Promoting Transparency and Healthy Competition in Medicare Act. All Provisions H.R. 2679 - The PBM Accountability Act. All Provisions. H.R. 2559 - The Strengthening Community Care Act of 2023. All Provisions. H.R. 2550 - The Special Diabetes Program Reauthorization Act of 2023. All Provisions H.R. 2547 - The Special Diabetes Program for Indians Reauthorization Act of 2023. All Provisions. H.R. 2665 - The Supporting Safety Net Hospitals Act. All Provisions. H.R. 1613 - The Drug Price Transparency in Medicaid Act of 2023. All Provisions. S. 1002, No Unreasonable Payments, Coding, or Diagnoses for Elderly (No UPCODE Act). All Provisions. S. 1182 - 340B - To amend the Public Health Service Act to increase the transparency and accountability of the drug discount program, and for other purposes. All Provisions.
Client expense: $175,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), Office of Management & Budget (OMB), SENATE
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), Office of Management & Budget (OMB), SENATE
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Client expense: $200,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
Client expense: $1,360,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, White House Office
Client expense: $175,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), Office of Management & Budget (OMB), SENATE
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
Government targets: HOUSE OF REPRESENTATIVES, SENATE